Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2002 Feb;25(1):31-50.
doi: 10.1385/MN:25:1:031.

Calcium channels and channelopathies of the central nervous system

Affiliations
Review

Calcium channels and channelopathies of the central nervous system

Daniela Pietrobon. Mol Neurobiol. 2002 Feb.

Abstract

Several inherited human neurological disorders can be caused by mutations in genes encoding Ca2+ channel subunits. This review deals with known human and mouse calcium channelopathies of the central nervous system (CNS). The human diseases comprise: 1) a recessive retinal disorder, X-linked congenital stationary night blindness, associated with mutations in the CACNA1F gene, encoding alpha(1)1.4 subunits of L-type channels; and 2) a group of rare allelic autosomal dominant human neurological disorders including familial hemiplegic migraine, episodic ataxia type 2, and spinocerebellar ataxia type 6, all associated with mutations in the CACNA1A gene, encoding alpha(1)2.1 subunits of P/Q-type calcium channels. Mutations at the mouse orthologue of the CACNA1A gene cause a group of recessive neurological disorders, including the tottering, leaner, and rocker phenotypes with ataxia and absence epilepsy, and the rolling Nagoya phenotype with ataxia without seizures. Two other spontaneous mouse mutants with ataxia and absence epilepsy, lethargic and stargazer, have mutations in genes encoding a calcium channel auxiliary beta subunit and a putative calcium channel auxiliary gamma subunit. For each channelopathy, the review describes disease phenotype, channel genotype, and known functional consequences of the pathological mutations; in some cases, it also describes working hypothesis and/or speculations addressing the challenging question of how the alterations in channel function lead to selective cellular dysfunction and disease.

PubMed Disclaimer

References

    1. Neuron. 2000 Mar;25(3):533-5 - PubMed
    1. Proc Natl Acad Sci U S A. 1999 Dec 21;96(26):15245-50 - PubMed
    1. J Neurosci. 2000 Jan 1;20(1):59-65 - PubMed
    1. FEBS Lett. 2000 Mar 24;470(2):189-97 - PubMed
    1. Invest Ophthalmol Vis Sci. 2001 Jun;42(7):1610-6 - PubMed

MeSH terms

Grants and funding

LinkOut - more resources